Oxidative stress is invariably involved in neurodegenerative insults as a contributing mechanism in various forms of cell death (Bains and Shaw 1997). If strategies have to be developed for protection against oxidative injury, a better understanding of how antioxidant defenses are maintained in the brain is required. In this issue, leading scientists in the field present the state of the art concerning how precursors of the main brain antioxidant glutathione are delivered to brain cells, and explore regulatory mechanisms to identify new neuroprotective strategies against neurodegenerative insults. The essence of these articles comes from lectures presented at the 11th International Congress on Amino Acids, Peptides and Proteins held in Vienna, August 3–7, 2009. The meeting was organized by Pr. G. Lubec and the session on glutamate, its transporters and antioxidant defenses by Dr. L. Had-Aissouni. Glutathione (GSH) is the main brain antioxidant molecule. It is a tripeptide composed of glutamate, cysteine and glycine. Substrates for GSH synthesis may be provided by direct transport of constituent amino acids from the extracellular milieu. In this context, cysteine is thought to be the limiting precursor for GSH synthesis. Indeed in the extracellular milieu it is oxidized into cystine and intracellularly (in the reduced form, cysteine) it is present at a lower concentration, compared to the other constituent of GSH in most cells. However, none of these amino acids is indispensable, so they can also be synthesized in cells from other amino acids, providing that the necessary metabolic pathways are present (McBean 2011). Moreover, released GSH or conjugates are substrates for the ectoenzyme gamma-glutamyltransferase (EC 2.3.2.2) forming dipeptides such as cysteinylglycine or gamma-glutamylcysteine that, after extracellular hydrolysis, may provide substrates for GSH synthesis. Dipeptides may also be transported intracellularly in some cells and in the case of gammaglutamylcysteine used to bypass the first step of GSH synthesis (Dringen 2000). Due to the different pathways that cells may use to obtain substrates for GSH synthesis, it is very unlikely that the activity of a single amino acid transport system is required to sustain GSH synthesis. However, data obtained in culture as well as in vivo suggest that plasma membrane glutamate transporters may be a determinant for maintenance of antioxidant defenses in the brain. Before cloning of the cDNA coding for amino acid transporter proteins or subunits, transport systems were identified and characterized according to functional criteria such as transport mechanism (exchange, uniport, cotransport, counter transport, primary or secondary active transport) substrate specificity (that is generally rather large) and ionic dependence (mainly sodium dependent or independent). These characteristics were first used to name the corresponding transport systems generally using the first letter of the preferred substrate or x for anionic amino acids or y for cationic amino acids, sodium-dependent transport systems being designated in upper case while sodium-independent transport system are generally designated in lower case. Moreover, the charge of the transported substrates may also be indicated in superscript (0, ?, or -) while the first letter of the preferred substrate may be indicated in subscript when not directly used to name the transport system. According to this nomenclature, glutamate was found to be transported inside cells in sodium-independent as well as sodium-dependent L. Had-Aissouni (&) Developmental Biology Institute of Marseille-Luminy, CNRS/Aix-Marseille University, Luminy Campus-Case 907, 13288 Marseille cedex 9, France e-mail: laurence.had-aissouni@univmed.fr